Causal Relationship Between Ferritin and Neuropsychiatric Disorders: A Two-Sample Mendelian Randomization Study

Overview

Journal J Alzheimers Dis Rep

Publisher IOS Press

Date 2024 Feb 26

PMID 38405340

Authors

Wenxian Sun

Cuibai Wei

Affiliations

Soon will be listed here.

Abstract

Background: Previous observational research has indicated a correlation between ferritin levels and neuropsychiatric disorders, although the causal relationship remains uncertain.

Objective: The objective of this study was to investigate the potential causal link between plasma ferritin levels and neuropsychiatric disorders.

Methods: A two-sample Mendelian randomization (MR) study was conducted, wherein genetic instruments associated with ferritin were obtained from a previously published genome-wide association study (GWAS). Summary statistics pertaining to neuropsychiatric disorders were derived from five distinct GWAS datasets. The primary MR analysis employed the inverse variance weighted (IVW) method and was corroborated by additional methods including MR-Egger, weighted median, simple mode, and weighted mode. Sensitivity analyses were employed to identify potential pleiotropy and heterogeneity in the results.

Results: The fixed effects IVW method revealed a statistically significant causal relationship between plasma ferritin level and the occurrence of Alzheimer's disease (odds ratio [OR] = 1.06, 95% confidence interval [CI]: 1.00-1.12, = 0.037), as well as Parkinson's disease (OR = 1.06, 95% CI: 1.00-1.13, = 0.041). Various sensitivity analyses were conducted, which demonstrated no substantial heterogeneity or pleiotropy. Conversely, no compelling evidence was found to support a causal association between ferritin and amyotrophic lateral sclerosis, schizophrenia, or major depressive disorder.

Conclusions: This MR study provides evidence at the genetic level for a causal relationship between plasma ferritin and an increased risk of Alzheimer's disease and Parkinson's disease. The exact genetic mechanisms underlying this connection necessitate further investigation.

References

Gao M, Monian P, Pan Q, Zhang W, Xiang J, Jiang X . Ferroptosis is an autophagic cell death process. Cell Res. 2016; 26(9):1021-32. PMC: 5034113. DOI: 10.1038/cr.2016.95. View

Bowden J, Del Greco M F, Minelli C, Zhao Q, Lawlor D, Sheehan N . Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption. Int J Epidemiol. 2018; 48(3):728-742. PMC: 6659376. DOI: 10.1093/ije/dyy258. View

Connor J, Snyder B, Arosio P, Loeffler D, Lewitt P . A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J Neurochem. 1995; 65(2):717-24. DOI: 10.1046/j.1471-4159.1995.65020717.x. View

Shamoto-Nagai M, Maruyama W, Yi H, Akao Y, Tribl F, Gerlach M . Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome. J Neural Transm (Vienna). 2005; 113(5):633-44. DOI: 10.1007/s00702-005-0410-5. View

Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen C . Alzheimer's disease. Lancet. 2021; 397(10284):1577-1590. PMC: 8354300. DOI: 10.1016/S0140-6736(20)32205-4. View

Lawlor D, Harbord R, Sterne J, Timpson N, Davey Smith G . Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2007; 27(8):1133-63. DOI: 10.1002/sim.3034. View

Emdin C, Khera A, Kathiresan S . Mendelian Randomization. JAMA. 2017; 318(19):1925-1926. DOI: 10.1001/jama.2017.17219. View

Ward R, Zucca F, Duyn J, Crichton R, Zecca L . The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 2014; 13(10):1045-60. PMC: 5672917. DOI: 10.1016/S1474-4422(14)70117-6. View

Licker V, Turck N, Kovari E, Burkhardt K, Cote M, Surini-Demiri M . Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson's disease pathogenesis. Proteomics. 2014; 14(6):784-94. DOI: 10.1002/pmic.201300342. View

10.

Hou W, Xie Y, Song X, Sun X, Lotze M, Zeh 3rd H . Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016; 12(8):1425-8. PMC: 4968231. DOI: 10.1080/15548627.2016.1187366. View

11.

Shi L, Huang C, Luo Q, Rogers E, Xia Y, Liu W . The Association of Iron and the Pathologies of Parkinson's Diseases in MPTP/MPP-Induced Neuronal Degeneration in Non-human Primates and in Cell Culture. Front Aging Neurosci. 2019; 11:215. PMC: 6729105. DOI: 10.3389/fnagi.2019.00215. View

12.

Bowden J, Del Greco M F, Minelli C, Davey Smith G, Sheehan N, Thompson J . A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017; 36(11):1783-1802. PMC: 5434863. DOI: 10.1002/sim.7221. View

13.

Wang Y, Li Y, Wu Z, Chen Z, Yu H, He Y . Ferritin disorder in the plasma and hippocampus associated with major depressive disorder. Biochem Biophys Res Commun. 2021; 553:114-118. DOI: 10.1016/j.bbrc.2021.03.059. View

14.

Fernandez T, Martinez-Serrano A, Cusso L, Desco M, Ramos-Gomez M . Functionalization and Characterization of Magnetic Nanoparticles for the Detection of Ferritin Accumulation in Alzheimer's Disease. ACS Chem Neurosci. 2018; 9(5):912-924. DOI: 10.1021/acschemneuro.7b00260. View

15.

Del Rey M, Mancias J . NCOA4-Mediated Ferritinophagy: A Potential Link to Neurodegeneration. Front Neurosci. 2019; 13:238. PMC: 6427834. DOI: 10.3389/fnins.2019.00238. View

16.

Ripke S, ODushlaine C, Chambert K, Moran J, Kahler A, Akterin S . Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 2013; 45(10):1150-9. PMC: 3827979. DOI: 10.1038/ng.2742. View

17.

Scheiber C, Schulz T, Schneider J, Bechter K, Schneider E . Old and New Biomarkers for Infection, Inflammation, and Autoimmunity in Treatment-Resistant Affective and Schizophrenic Spectrum Disorders. Pharmaceuticals (Basel). 2022; 15(3). PMC: 8949012. DOI: 10.3390/ph15030299. View

18.

Sun B, Maranville J, Peters J, Stacey D, Staley J, Blackshaw J . Genomic atlas of the human plasma proteome. Nature. 2018; 558(7708):73-79. PMC: 6697541. DOI: 10.1038/s41586-018-0175-2. View

19.

Koziorowski D, Friedman A, Arosio P, Santambrogio P, Dziewulska D . ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control. Parkinsonism Relat Disord. 2007; 13(4):214-8. DOI: 10.1016/j.parkreldis.2006.10.002. View

20.

Wang L, Li C, Chen X, Li S, Shang H . Abnormal Serum Iron-Status Indicator Changes in Amyotrophic Lateral Sclerosis (ALS) Patients: A Meta-Analysis. Front Neurol. 2020; 11:380. PMC: 7251146. DOI: 10.3389/fneur.2020.00380. View